| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2001 | CN1294912A Blood sugar reducing compound |
| 05/16/2001 | CN1294911A Substituted nitrobenzene derivative for medicine and other use |
| 05/16/2001 | CN1294910A Acne and mite treating liniment |
| 05/16/2001 | CN1294903A Wound medicine moisture maintaining dressing |
| 05/16/2001 | CN1065863C N-substituted dioxothiazolidylbenzamide derivatives and process for producing same |
| 05/16/2001 | CN1065862C N-(2-amino-4, 6-pyrimidine bichloride-5-) formamide and preparation of same |
| 05/16/2001 | CN1065861C Phenyl substituted alkenocarboxylic guanidine, preparation method application as medicine or diagnostic agent and medicine containing it |
| 05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/15/2001 | USRE37180 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/15/2001 | US6232468 Antiinflammatory agent |
| 05/15/2001 | US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders |
| 05/15/2001 | US6232438 Angiotensin converting enzyme inhibitors |
| 05/15/2001 | US6232434 Polymers for delivering nitric oxide in vivo |
| 05/15/2001 | US6232350 Administering triphenylethylene antiestrogens (tamoxifen and derivatives-neuroprotectants) to act as cell-nucleus receptor blockers |
| 05/15/2001 | US6232349 And polycarbonates, polyesters or polyamides water-soluble, with a rigid backbone and predictable anion spacing |
| 05/15/2001 | US6232348 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 05/15/2001 | US6232347 Treatment of osteoarthritis |
| 05/15/2001 | US6232346 Composition for improvement of cellular nutrition and mitochondrial energetics |
| 05/15/2001 | US6232345 Cerebral function improving agents |
| 05/15/2001 | US6232344 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
| 05/15/2001 | US6232343 A 4,8-inter-m-phenylene prostaglandin 2 derivative for decreasing ocular tension, which has therapeutic and prevention effects against ophthalmic diseases such as glaucoma, hypertonia oculi or cataract |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232341 Topical pharmaceutical compositions for healing wounds |
| 05/15/2001 | US6232340 Vanadium complexes and derivatives thereof and methods related thereto |
| 05/15/2001 | US6232338 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 05/15/2001 | US6232337 Useful in the treatment of type ii diabetes and obesity |
| 05/15/2001 | US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 05/15/2001 | US6232335 2,4-Dioxopyrrolidine and 2,4-dioxotetrahydrofan derivatives and medicines containing the same at the active ingredient |
| 05/15/2001 | US6232333 A solution in a organic solvent (mixture of ethanol and linoleic acid) of the hiv protease inhibitor (ritonavir), and a surfactant (polyoxyl 35 castor oil) optionally encapsulated in hard gelatin capsules or soft elastic capsules (sec) |
| 05/15/2001 | US6232331 Benzofuroxan derivatives, their therapeutic uses and pharmaceutical compositions |
| 05/15/2001 | US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat) |
| 05/15/2001 | US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles |
| 05/15/2001 | US6232328 Non-systemic control of parasites |
| 05/15/2001 | US6232327 And physiologically tolerable acid addition salts, n-oxides |
| 05/15/2001 | US6232326 Treatment for schizophrenia and other dopamine system dysfunctions |
| 05/15/2001 | US6232325 Thrombosis therapy |
| 05/15/2001 | US6232324 Use of pyrazolopyridine compound |
| 05/15/2001 | US6232323 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 05/15/2001 | US6232322 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232319 Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |
| 05/15/2001 | US6232316 Such as parkinson's disease, tourette's syndrome, schizophrenia, and senile dementia of alzheimers disease |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | US6232314 Arylalkylpiperazine compounds as antioxidants |
| 05/15/2001 | US6232313 Pyridazino quinoline compounds |
| 05/15/2001 | US6232312 Administering a combination of indene and pyrimido(5,4-d)pyrimidine derivatives to treat prepancreatic cancer |
| 05/15/2001 | US6232311 Administering an orally active, long acting, central nervous system-penetrant tachykinin receptor particularly neurokinin-1 receptor antagonist |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | US6232307 2-phenyl-1-(4-(2-aminoethoxy)-benzyl)-indole compounds useful as estrogenic agents |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232304 Inclusion complexes of aryl-heterocyclic salts |
| 05/15/2001 | US6232301 Administering to the inside of a patient's bladder a solution of hyaluronic acid and/or its salts to promote vesical mucosa epithelium dilation |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6232299 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
| 05/15/2001 | US6232298 Administering uridine, cytidine, or orotic acid or salt or acylated derivative to treat cachexia |
| 05/15/2001 | US6232297 Methods and compositions for treating inflammatory response |
| 05/15/2001 | US6232294 Glycosyl vitamin p and trehalose; nervous system, sleep, eating, psychological, and gastrointestinal disorders |
| 05/15/2001 | US6232287 Peptide targets prostate gland; diagnosis; drug delivery; biochemical conjugation |
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/15/2001 | US6232082 Vaccines |
| 05/15/2001 | US6232071 Tenascin-C nucleic acid ligands |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | US6231894 Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| 05/15/2001 | US6231890 Suspension of sparingly water-soluble acidic drug |
| 05/15/2001 | US6231888 Drug delivery for drugs with cores and coatings |
| 05/15/2001 | US6231887 Drugs of pyranone derivatives |
| 05/15/2001 | US6231886 Methods of providing sustained treatment with opioids |
| 05/15/2001 | US6231884 Plasters for antiischemic agents |
| 05/15/2001 | US6231880 Antigrowth agents for cells by stimulating to patients and effective dimethyl substituted carboxylic acid |
| 05/15/2001 | US6231875 Acidified composition for topical treatment of nail and skin conditions |
| 05/15/2001 | US6231874 Moisturizers |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231862 Purified new epididymal forward motility protein and a process for the isolation of the said epididymal forward motility protein useful as a fertility prometer/blocker |
| 05/15/2001 | US6231860 Stabilizers for live vaccines |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231852 Method for reducing BCL-2 expressing cells resistance to death |
| 05/15/2001 | US6231847 Inhibiting a vascular proliferative response in injured vasculature resulting from a medical procedure, comprising intravenously administering to the patient polyarginine antiproliferative agent |
| 05/15/2001 | US6231840 An alkanoic acid in aqueous solution is useful for treating mammalian nail fungal conditions |
| 05/15/2001 | US6231833 Administering to the mammal for treating serotonin system related disorders an effective amount of 2,7-substituted octahydro-1h-pyrido(1,2-a)pyrazine derivative as ligands for serotonin receptor |
| 05/15/2001 | US6231605 Frozen and thawed in mold to create interlocking mesh; expanded and immersed in water solution; human tissue replacement; biocompatibility |
| 05/15/2001 | US6231594 Method of controlling body temperature while reducing shivering |
| 05/15/2001 | US6231536 Method and compositions for treatments of cancers |
| 05/15/2001 | US6231259 Viscous product dispenser with porous dome |
| 05/15/2001 | CA2325667A1 Anti-malignant tumor agent used in malignant neoplasms including cancers |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/15/2001 | CA2196539C Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/15/2001 | CA2173729C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/15/2001 | CA2154663C Polyamine derivatives as radioprotective agents |
| 05/15/2001 | CA2034612C Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
| 05/15/2001 | CA2023008C 4-substituted 17.beta. -(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds useful as c17-20 lyase inhibitors |
| 05/15/2001 | CA2009669C Novel n-¬substituted aryl|-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| 05/10/2001 | WO2001033223A1 Composite nanospheres and their conjugates with biomolecules |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | WO2001032923A1 Antisense inhibition of pi3 kinase p55 gamma expression |